CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $728,924
- in 5 filings
Net −$728,924. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-16 | Chen Richard Chief Medical Officer and EVP | Sale | −4,817 | $2.07 | $10K | 125,529 |
| 2023-06-16 | Tachibana Aaron CFO and COO | Sale | −6,904 | $2.07 | $14K | 193,990 |
| 2023-06-13 | WIDDER KENNETH J Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2023-05-17 | MYERS WOODROW A JR Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-05-17 | Bloom Olivia Kyusuk Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-05-17 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-05-17 | Shoff Lonnie Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-05-17 | Colowick Alan Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-05-17 | BOWMAN A BLAINE Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-05-17 | Tachibana Aaron CFO and COO | Sale | −1,389 | $1.98 | $3K | 200,894 |
| 2023-05-17 | Moore Stephen Michael General Counsel | Sale | −1,781 | $1.98 | $4K | 81,627 |
| 2023-05-17 | Chen Richard Chief Medical Officer and EVP | Sale | −971 | $1.98 | $2K | 130,346 |
| 2023-05-02 | Moore Stephen Michael General Counsel | Sale | −5,102 | $2.29 | $12K | 83,408 |
| 2023-03-17 | Tachibana Aaron CFO and COO | Sale | −3,945 | $2.83 | $11K | 202,283 |
| 2023-03-17 | Chen Richard Chief Medical Officer and EVP | Sale | −1,314 | $2.83 | $4K | 131,317 |
| 2023-03-15 | Moore Stephen Michael General Counsel | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-03-15 | Chen Richard Chief Medical Officer and EVP | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-03-15 | Tachibana Aaron CFO and COO | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2023-03-15 | Hall Christopher M President and CEO | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2023-01-31 | Tachibana Aaron Chief Financial Officer | Sale | −767 | $2.20 | $2K | 206,228 |
Page 8 of 23 · 444 trades